Tiotiu Angelica, Badi Yusef, Kermani Nazanin Zounemat, Sanak Marek, Kolmert Johan, Wheelock Craig E, Hansbro Philip M, Dahlén Sven-Erik, Sterk Peter J, Djukanovic Ratko, Guo Yike, Mumby Sharon, Adcock Ian M, Chung Kian Fan
National Heart and Lung Institute and.
Department of Pulmonology, University Hospital of Nancy, Nancy, France.
Am J Respir Crit Care Med. 2022 Feb 15;205(4):397-411. doi: 10.1164/rccm.202102-0355OC.
Mast cells (MCs) play a role in inflammation and both innate and adaptive immunity, but their involvement in severe asthma (SA) remains undefined. We investigated the phenotypic characteristics of the U-BIOPRED (Unbiased Biomarkers for the Prediction of Respiratory Diseases Outcomes) asthma cohort by applying published MC activation signatures to the sputum cell transcriptome. Eighty-four participants with SA, 20 with mild/moderate asthma (MMA), and 16 healthy participants without asthma were studied. We calculated enrichment scores (ESs) for nine MC activation signatures by asthma severity, sputum granulocyte status, and three previously defined sputum molecular phenotypes or transcriptome-associated clusters (TACs) 1, 2, and 3 using gene set variation analysis. MC signatures except unstimulated, repeated FcεR1-stimulated and IFN-γ-stimulated signatures were enriched in SA. A FcεR1-IgE-stimulated and a single-cell signature from asthmatic bronchial biopsies were highly enriched in eosinophilic asthma and in the TAC1 molecular phenotype. Subjects with a high ES for these signatures had elevated sputum amounts of similar genes and pathways. IL-33- and LPS-stimulated MC signatures had greater ES in neutrophilic and mixed granulocytic asthma and in the TAC2 molecular phenotype. These subjects exhibited neutrophil, NF-κB (nuclear factor-κB), and IL-1β/TNF-α (tumor necrosis factor-α) pathway activation. The IFN-γ-stimulated signature had the greatest ES in TAC2 and TAC3 that was associated with responses to viral infection. Similar results were obtained in an independent ADEPT (Airway Disease Endotyping for Personalized Therapeutics) asthma cohort. Gene signatures of MC activation allow the detection of SA phenotypes and indicate that MCs can be induced to take on distinct transcriptional phenotypes associated with specific clinical phenotypes. IL-33-stimulated MC signature was associated with severe neutrophilic asthma, whereas IgE-activated MC was associated with an eosinophilic phenotype.
肥大细胞(MCs)在炎症以及先天性和适应性免疫中发挥作用,但其在重度哮喘(SA)中的作用仍不明确。我们通过将已发表的MC激活特征应用于痰液细胞转录组,研究了U-BIOPRED(用于预测呼吸系统疾病结局的无偏生物标志物)哮喘队列的表型特征。研究了84名SA患者、20名轻度/中度哮喘(MMA)患者和16名无哮喘的健康参与者。我们使用基因集变异分析,根据哮喘严重程度、痰液粒细胞状态以及三种先前定义的痰液分子表型或转录组相关簇(TACs)1、2和3,计算了九种MC激活特征的富集分数(ESs)。除未刺激、重复FcεR1刺激和IFN-γ刺激的特征外,MC特征在SA中富集。来自哮喘支气管活检的FcεR1-IgE刺激特征和单细胞特征在嗜酸性粒细胞性哮喘和TAC1分子表型中高度富集。这些特征ES高的受试者痰液中相似基因和通路的含量升高。IL-33和LPS刺激的MC特征在中性粒细胞性和混合粒细胞性哮喘以及TAC2分子表型中具有更大的ES。这些受试者表现出中性粒细胞、NF-κB(核因子κB)和IL-1β/TNF-α(肿瘤坏死因子-α)通路激活。IFN-γ刺激特征在与病毒感染反应相关的TAC2和TAC3中具有最大的ES。在独立的ADEPT(个性化治疗气道疾病分型)哮喘队列中获得了类似结果。MC激活的基因特征能够检测SA表型,并表明MC可被诱导呈现与特定临床表型相关的不同转录表型。IL-33刺激的MC特征与严重中性粒细胞性哮喘相关,而IgE激活的MC与嗜酸性粒细胞表型相关。